Research Article Details
Article ID: | A23280 |
PMID: | 23900558 |
Source: | Dig Dis Sci |
Title: | Fatty liver disease index: a simple screening tool to facilitate diagnosis of nonalcoholic fatty liver disease in the Chinese population. |
Abstract: | BACKGROUND AND OBJECTIVES: A simple screening tool is needed as an aid to optimize management of nonalcoholic fatty liver disease (NAFLD). The purpose of this study was to design a simple index that could be used to predict the presence of NAFLD. METHODS: A cross-sectional case-control study design was used for this study with 6,926 subjects who had received health assessments. RESULTS: Multivariate analysis indicated that body mass index (BMI), triglyceride (TG), alanine aminotransferase (ALT) to aspartate aminotransferase (AST) ratio (ALT/AST ratio), and hyperglycemia (HG) were independent risk factors for NAFLD. These variables were used to construct a fatty liver disease (FLD) index: FLD index = BMI + TG + 3 × (ALT/AST ratio) + 2 × HG (presence of HG, HG = 1; absence of HG, HG = 0). The FLD index had an area under the receiver-operating characteristic (AUROC) curve of 0.819 in the training set and 0.817 in the validation set. Values of the FLD index <28.0 or >37.0 excluded the possibility of NAFLD with sensitivity of 94.9 % or detected NAFLD with specificity of 96.0 %, respectively. CONCLUSIONS: The FLD index is a simple, efficient NAFLD screening tool for the Chinese population that may be used to select people for further analysis and/or treatment, and/or for lifestyle modification. |
DOI: | 10.1007/s10620-013-2774-y |

Strategy ID | Therapy Strategy | Synonyms | Therapy Targets | Therapy Drugs |
---|
Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
---|
Diseases ID | DO ID | Disease Name | Definition | Class | |
---|---|---|---|---|---|
I05 | 9352 | Type 2 diabetes mellitus | A diabetes that is characterized by chronic hyperglycaemia with disturbances of carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, insulin action, or both. A diabetes mellitus that is characterized by high blood sugar, insulin resistance, and relative lack of insulin. http://en.wikipedia.org/wiki/Diabetes, http://en.wikipedia.org/wiki/Diabetes_mellitus_type_2 | disease of metabolism/inherited metabolic disorder/ carbohydrate metabolic disorder/glucose metabolism disease/diabetes/ diabetes mellitus | Details |
Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress | |
---|---|---|---|---|---|---|---|
D080 | Citrulline | Chemical drug | DB00155 | -- | -- | Under clinical trials | Details |
D579 | Emfilermin | Miscellany | -- | adipocytes | Enhance lipid metabolism | Under investigation | Details |
D199 | L-alanine | Chemical drug | DB00160 | KYNU | -- | Failed in clinical trials | Details |